SEI Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.31M | Buy |
17,542
+1,547
| +10% | +$468K | 0.01% | 1248 |
|
2025
Q1 | $5.3M | Buy |
15,995
+7,766
| +94% | +$2.57M | 0.01% | 1243 |
|
2024
Q4 | $2.54M | Sell |
8,229
-1,023
| -11% | -$316K | ﹤0.01% | 1589 |
|
2024
Q3 | $1.96M | Sell |
9,252
-547
| -6% | -$116K | ﹤0.01% | 1695 |
|
2024
Q2 | $2.75M | Sell |
9,799
-656
| -6% | -$184K | ﹤0.01% | 1508 |
|
2024
Q1 | $2.79M | Sell |
10,455
-463
| -4% | -$124K | ﹤0.01% | 1473 |
|
2023
Q4 | $2.53M | Buy |
10,918
+830
| +8% | +$192K | ﹤0.01% | 1498 |
|
2023
Q3 | $1.47M | Sell |
10,088
-3,176
| -24% | -$464K | ﹤0.01% | 1734 |
|
2023
Q2 | $3.06M | Buy |
13,264
+5,221
| +65% | +$1.21M | 0.01% | 1443 |
|
2023
Q1 | $1.95M | Buy |
8,043
+2,779
| +53% | +$673K | ﹤0.01% | 1638 |
|
2022
Q4 | $1.53M | Buy |
+5,264
| New | +$1.53M | ﹤0.01% | 1606 |
|
2022
Q2 | – | Sell |
-2,823
| Closed | -$277K | – | 2690 |
|
2022
Q1 | $277K | Buy |
2,823
+80
| +3% | +$7.85K | ﹤0.01% | 2334 |
|
2021
Q4 | $232K | Sell |
2,743
-234
| -8% | -$19.8K | ﹤0.01% | 2425 |
|
2021
Q3 | $238K | Hold |
2,977
| – | – | ﹤0.01% | 2394 |
|
2021
Q2 | $290K | Buy |
+2,977
| New | +$290K | ﹤0.01% | 2325 |
|
2019
Q1 | – | Sell |
-465
| Closed | -$100K | – | 2947 |
|
2018
Q4 | $100K | Hold |
465
| – | – | ﹤0.01% | 2198 |
|
2018
Q3 | $100K | Sell |
465
-5,291
| -92% | -$1.14M | ﹤0.01% | 2080 |
|
2018
Q2 | $1.61M | Buy |
+5,756
| New | +$1.61M | 0.01% | 1408 |
|